Načítá se...
Donepezil Adherence, Persistence and Time to First Discontinuation in a Three-Year Follow-Up of Older People
BACKGROUND: Donepezil is indicated for the management of mild to moderate dementia, particularly in Alzheimer's disease. Several studies have described low adherence rates with donepezil. AIM: To examine and measure donepezil adherence, persistence and time to first discontinuation in older New...
Uloženo v:
| Vydáno v: | Dement Geriatr Cogn Dis Extra |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4777950/ https://ncbi.nlm.nih.gov/pubmed/26955381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000441894 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|